Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2023
March 2023, Vol 13, No 3
March 2023, Vol 13, No 3
Darolutamide Extends Survival in Metastatic Hormone-Sensitive Prostate Cancer
By
Anne Rowe
ASCO GU 2023 Highlights
,
Prostate Cancer
An analysis from the ARASENS trial showed that the addition of darolutamide (Nubeqa) to androgen-deprivation therapy (ADT) and docetaxel significantly improved overall survival (OS) in subgroups of patients with metastatic hormone-sensitive prostate cancer (mHSPC) with high-volume and high-risk disease and should be considered the new standard of care for this patient population.
Read More ›
Study Finds Disparities in Access to Opioids for Cancer Pain at End of Life
Disparities in Cancer Care
Older Black and Hispanic patients with advanced cancer are less likely than White patients to receive opioid medications for pain relief in the last weeks of life, according to the results of a recent study.
Read More ›
Researchers 3D Bioprint Breast Cancer Tumors, Treat Them in Groundbreaking Study
By
Adrienne Berard
Healthcare Technology
,
Breast Cancer
Researchers at Penn State have successfully 3D bioprinted breast cancer tumors and treated them in a breakthrough study to better understand the disease that is one of the leading causes of mortality worldwide.
Read More ›
Choosing Adjuvant Therapies in Patients with RCC Requires Careful Consideration of Risks and Benefits
By
William King
ASCO GU 2023 Highlights
,
Renal-Cell Carcinoma
The decision to use adjuvant therapies in patients with renal-cell carcinoma (RCC) should be based on risk, patient goals, and shared decision-making. This topic was explored in a presentation by Matthew Zibelman, MD.
Read More ›
IQVIA Predicts US Spending on Biosimilars Will Reach $129 Billion by 2027
Biosimilars
Anticipated launches and uptake of biosimilars are predicted to increase spending to $129 billion and savings by $180 billion over the next 5 years, according to a report by IQVIA.
Read More ›
Increased Use of Telehealth Could Reduce Financial Burden of Oncology Services for Some Patients
Telehealth
Results from a recent study by Krupal B. Patel, MD, MSc, FRCSC, Surgeon, Department of Head and Neck–Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, and colleagues indicate that the adoption of telehealth services during the pandemic saved patients with cancer both time and travel costs, reducing the cost burden associated with their care.
Read More ›
Young Women with Breast Cancer May Safely Pause Endocrine Therapy to Pursue Pregnancy
By
Patricia Stewart
Women's Health
,
Breast Cancer
,
SABCS 2022 Highlights
Young women with early-stage, hormone receptor (HR)-positive breast cancer attempting to become pregnant can safely pause endocrine therapy and resume it later, according to initial results from the international POSITIVE trial.
Read More ›
RIT Researcher Develops Math Models to Help Predict Patients’ Medication Adherence
By
Luke Auburn
In the Literature
In a new study published in the
Journal of Managed Care & Specialty Pharmacy
, Teresa Gibson, PhD, Professor of Practice, School of Mathematical Sciences, RIT, showed that an individual’s previous adherence behavior is an important predictor of future adherence.
Read More ›
The End of the COVID-19 Public Health Emergency: What Are the Implications for Your Practice?
By
Shawntea (Taya) Gordon, MBA, FACMPE, CMOM
Practice Management
President Biden announced that the public health emergency (PHE) will expire on May 11, 2023. Providers need to review the impact of these upcoming changes, in addition to any others that bear weight on the financial stability of their practices or the ability of patients to access the care they need.
Read More ›
Orserdu FDA Approved for ER-Positive, Advanced or Metastatic Breast Cancer with ESR1 Mutation
FDA Approvals, News & Updates
,
Breast Cancer
On
January 27, 2023
, the FDA approved elacestrant (Orserdu; Stemline Therapeutics), an estrogen receptor (ER) antagonist, for the treatment of postmenopausal women or adult men with ER-positive,
HER2
-negative advanced or metastatic breast cancer and an
ESR1
mutation whose disease progressed after ≥1 line of endocrine therapy.
Read More ›
Page 1 of 2
1
2
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Out Models Cost Patients and Employers More Than They Disclose
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
By
Marianne Davies, DNP, ACNP, AOCNP, FAAN
;
Shawn Perkins, RN, BSN, OCN
3.
Dexamethasone-Sparing Regimen Safe and Effective in Frail Patients with Multiple Myeloma
By
William King
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes